Letter from DSIT Secretary of State Liz Kendall to Ofcom Chair, Sir Ian Cheshire.
Jun102026
Jun102026
Letter from DSIT Secretary of State Liz Kendall to Ofcom Chair, Sir Ian Cheshire.
Jun102026
The CHP’s preliminary investigation revealed that the boy had not received COVID-19 vaccine and had mostly stayed in Hong Kong throughout the incubation period. His three household contacts remain asymptomatic so far.
Government’s COVID-19 Vaccination Programme
————————————————————-
“Scientific evidence shows that COVID-19 vaccines are effective in reducing the risk of severe disease and death. Although COVID-19 has become a common respiratory infection in Hong Kong and around the world, certain high-risk individuals, especially young children, who have not received their initial dose of the COVID-19 vaccine and have not developed immunity through natural infection, face a higher risk of serious complications if they become infected. I would like to specifically remind the public that individuals who have not yet received their initial dose of the COVID-19 vaccine (including children aged six months or above) should get vaccinated as soon as possible, while high-risk individuals (particularly the elderly and those with underlying comorbidities) should also receive booster dose at appropriate times for effective protection against COVID-19.” said the Controller of the CHP, Dr Edwin Tsui.
“According to the latest surveillance data, while the overall local activity of COVID-19 still remains at a relatively low level, slight increases have been recorded continually since early May. The COVID-19 activity levels fluctuate, with an upsurge period generally occurred approximately every six to nine months in recent years. Each upsurge is associated with changes in predominant circulating variants and a decline in community herd immunity. It has been nearly a year since the end of the last periodic upsurge of COVID-19 activity in Hong Kong, and it cannot be ruled out that the overall COVID-19 activity will rise further in the coming one to two months,” he added.
The shelf life of the vaccines provided under the Government’s COVID-19 Vaccination Programme (the Programme) is going to expire. A new batch of vaccines will arrive in Hong Kong successively in the fourth quarter of 2026. During this transition period, eligible individuals will not be able to receive free COVID-19 vaccines through the Programme for a short period. As such, those in need are advised to make appointments as early as possible. Existing vaccination services will continue until the following dates:
Apart from vaccination, in order to prevent COVID-19, influenza, and other respiratory illnesses as well as transmission in the community, the public should maintain strict personal and environmental hygiene at all times and note the following:
For more information on the COVID-19 Vaccination Programme and the latest recommendations on vaccine use, please refer to the CHP’s website.
Jun102026
A list of the roles of those currently granted pre-release access to our key official statistics.
Jun102026
The London sandbox is a secure environment designed to safely test AI-enabled devices in a real-world environment so patients can benefit more quickly.
Jun102026
The Health and Safety Executive (HSE) and the Regulatory Innovation Office (RIO) are working together, along with government and industry, to support the safe and responsible adoption of robotics in the workplace.
The project, launched today, 10 June 2026, at London Tech Week, has been co-designed with industry to give companies clarity on regulatory requirements, and support businesses to increase the use of robotics.
HSE will partner with Automate UK and the Manufacturing Technology Centre (MTC) to create practical guidance on how collaborative robots (cobots) can safely work alongside humans – combining industry good practice with HSE regulatory expertise .
The first stage, launching this summer will deliver regulatory clarity for cobots. It will give industry confidence in how they can ensure robots can work safely alongside humans.
Andrew Curran CBE, Director of Science and Chief Scientific Adviser at the Health and Safety Executive, said: “We recognise how guidance and advice can give employers the confidence to innovate safely and provide a platform for new technology to improve productivity and enable growth.
“We understand that despite there being no barrier to adoption in health and safety law there is a fear of non-compliance, which is limiting adoption. Therefore, we are committed to working with the Regulatory Innovation Office and industry partners to deliver the first joint HSE and industry guidance on the use of cobots to address this barrier and improve business confidence.”
More information